Advertisement

Einleitung

Chapter
  • 34 Downloads

Zusammenfassung

Das TNM-System zur Klassifikation der malignen Tumoren wurde von P. Denoix (Frankreich) in den Jahren 1943–19521 entwickelt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Denoix PF (1944) Bull Inst Nat Hyg (Paris) 1: 1–69; 5: 52–82.Google Scholar
  2. 2.
    WHO Technical Report Series (1952), Nr. 53, Juli.Google Scholar
  3. 3.
    International Union Against Cancer (UICC) (1958) Committee on Clinical Stage Classification and Applied Statistics: Clinical stage classification and presentation of results. Malignant tumours of the breast and larynx. Paris.Google Scholar
  4. 4.
    International Union Against Cancer (UICC)(1959) Committee on Clinical Stage Classification and Applied Statistics: Clinical stage classification and presentation of results. Malignant tumours of the breast. Paris.Google Scholar
  5. 5.
    International Union Against Cancer (UICC) (1968) TNM Classification of Malignant Tumours. Geneva.Google Scholar
  6. 6.
    International Union Against Cancer (UICC) (1969) TNM General Rules. Geneva.Google Scholar
  7. 7.
    International Union Against Cancer (UICC) (1974) TNM Classification of Malignant Tumours, 2nd edn. Geneva.Google Scholar
  8. 8.
    International Union Against Cancer (UICC): Harmer MH (ed) (1978) TNM Classification of Malignant Tumours, 3rd edn., enlarged and revised 1982. Geneva.Google Scholar
  9. 9.
    International Union Against Cancer (UICC): Hermanek P, Sobin LH (eds) (1987) TNM Classification of Malignant Tumours, 4th edn, revised 1992. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  10. 10.
    International Union Against Cancer (UICC): Hermanek P, Henson DE, Hutter RVP, Sobin LH (eds) ( 1993 ) TNM Supplement 1993. A commentary on uniform use. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  11. 11.
    International Union Against Cancer (UICC): Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) (1995) Prognostic factors in cancer. Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  12. 12.
    Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O’Sullivan B, Sobin LH, Yarbo JW (eds) (1997) AJCC Cancer Staging Manual, 5th edn. Lippincott, PhiladelphiaGoogle Scholar
  13. 13.
    Percy G, Holten V van, Muir C (eds) (1990) International Classification of diseases for oncology, 2nd edn. World Health Organization, Geneva. Wagner G. (Hrsg) (1993) Tumorlokalisationsschlüssel. 5. Aufl. (deutsche Ausgabe des Topographieteils der ICD-O) Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  14. Percy G, Holten V van, Muir C (eds) (1990) International Classification of diseases for oncology, 2nd edn. World Health Organization, Geneva. Wagner G. (Hrsg) (1993) Tumorlokalisationsschlüssel. 5. Aufl. (deutsche Ausgabe des Topographieteils der ICD-O) Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  15. 14.
    Percy G, Holten V van, Muir C (eds) (1990) International Classification of diseases for oncology, 2nd edn. World Health Organization, Geneva. Wagner G. (Hrsg) (1993) Tumorlokalisationsschlüssel. 5. Aufl. (deutsche Ausgabe des Topographieteils der ICD-O) Springer, Berlin Heidelberg New York Tokyo.Google Scholar
  16. 15.
    Percy G, Holten V van, Muir C (eds) (1990) International Classification of diseases for oncology, 2nd edn. World Health Organization, Geneva. Wagner G. (Hrsg) (1993) Tumorlokalisationsschlüssel. 5. Aufl. (deutsche Ausgabe des Topographieteils der ICD-O) Springer, Berlin Heidelberg New York Tokyo.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  1. 1.Institut für Pathologie der UniversitätLeipzigDeutschland
  2. 2.Deutsches KrebsforschungszentrumHeidelbergDeutschland

Personalised recommendations